Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

27%

6 trials in Phase 3/4

Results Transparency

36%

5 of 14 completed with results

Key Signals

5 with results93% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (6)
P 1 (3)
P 2 (3)
P 3 (3)
P 4 (3)

Trial Status

Completed14
Recruiting5
Unknown2
Terminated1

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT00796146RecruitingPrimary

Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population

NCT05719441Phase 2RecruitingPrimary

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

NCT06484335Phase 1Recruiting

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV

NCT00796263Phase 3RecruitingPrimary

Antiretroviral Therapy for Acute and Chronic HIV Infection

NCT02475915Phase 1CompletedPrimary

Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection

NCT03711253Phase 4UnknownPrimary

Empiric Treatment for Acute HIV in the ED

NCT05728996RecruitingPrimary

Netherlands Cohort Study on Acute HIV Infection

NCT01197027Phase 3CompletedPrimary

Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection

NCT02384395Not ApplicableCompleted

Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection

NCT03579381Completed

Specimen Repository for HIV Immunopathogenesis

NCT02170246Phase 1CompletedPrimary

Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection

NCT02467439Not ApplicableCompletedPrimary

Acute Partner and Social Contact Referral: iKnow

NCT01434706Not ApplicableCompletedPrimary

Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection

NCT02750059Phase 2CompletedPrimary

Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis

NCT02231281Phase 3UnknownPrimary

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

NCT00855413Phase 4TerminatedPrimary

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

NCT00924898Phase 4CompletedPrimary

Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

NCT02614950Not ApplicableCompletedPrimary

Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection

NCT00734344Not ApplicableCompletedPrimary

Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection

NCT01369056Not ApplicableCompletedPrimary

HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence

Scroll to load more

Research Network

Activity Timeline